お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は女性の健康市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは女性の健康の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の女性の健康市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは女性の健康のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に女性の健康市場を分類しています。本研究に含まれる主な企業は：Allergan、Bayer、Merck、Pfizer、Teva Pharmaceutical、Agile Therapeutics、Amgen、Apothecus Pharmaceutical、AstraZeneca、Blairex Laboratories、Bristol-Myers Squibb、Ferring

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Postmenopausal Osteoporosis
    Endometriosis
    Polycystic Ovary Syndrome
    Infertility
    Menopause
    Others

用途別の市場セグメント：
    Hospitals
    Clinics
    Others

本レポートの詳細内容
世界の女性の健康市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、女性の健康タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の女性の健康収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の女性の健康市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、女性の健康市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

女性の健康のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：女性の健康のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：女性の健康の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章女性の健康企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：女性の健康の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：女性の健康の主要企業の概要を提供し、製品の説明と仕様、女性の健康の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Women are more prone to certain diseases, such as osteoporosis, osteoarthritis, anemia, menstruation-related disorders, depression, and obesity. Hence, increase in incidence of these conditions is likely to boost the market in the coming years.
Market Analysis and Insights: Global Womens Health Market
The global Womens Health market is projected to grow from US$ 33610 million in 2024 to US$ 44780 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.9% during the forecast period.
Government and various private organizations are working toward improving women’s health across the world, and this is likely to drive growth in the coming years. Reimbursement coverage provided to women is also a key factor driving the market in developed countries. For instance, various coverage plans in the U.S. provide preventive services for women without charging any copayment. These include screening for anemia, hepatitis B, & breast cancer on a routine basis, folic acid supplements for women who are likely to be pregnant, and contraceptive methods, among others.
Report Covers:
This report presents an overview of global market for Womens Health market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Womens Health, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Womens Health, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Womens Health revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Womens Health market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Womens Health revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Allergan, Bayer, Merck, Pfizer, Teva Pharmaceutical, Agile Therapeutics, Amgen, Apothecus Pharmaceutical and AstraZeneca, etc.

Market Segmentation
By Company
    Allergan
    Bayer
    Merck
    Pfizer
    Teva Pharmaceutical
    Agile Therapeutics
    Amgen
    Apothecus Pharmaceutical
    AstraZeneca
    Blairex Laboratories
    Bristol-Myers Squibb
    Ferring

Segment by Type
    Postmenopausal Osteoporosis
    Endometriosis
    Polycystic Ovary Syndrome
    Infertility
    Menopause
    Others

Segment by Application
    Hospitals
    Clinics
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Womens Health in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Womens Health companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Womens Health revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Womens Health Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Postmenopausal Osteoporosis
    Table 3. Key Players of Endometriosis
    Table 4. Key Players of Polycystic Ovary Syndrome
    Table 5. Key Players of Infertility
    Table 6. Key Players of Menopause
    Table 7. Key Players of Others
    Table 8. Global Womens Health Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 9. Global Womens Health Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 10. Global Womens Health Market Size by Region (2019-2024) & (US$ Million)
    Table 11. Global Womens Health Market Share by Region (2019-2024)
    Table 12. Global Womens Health Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 13. Global Womens Health Market Share by Region (2025-2030)
    Table 14. Womens Health Market Trends
    Table 15. Womens Health Market Drivers
    Table 16. Womens Health Market Challenges
    Table 17. Womens Health Market Restraints
    Table 18. Global Womens Health Revenue by Players (2019-2024) & (US$ Million)
    Table 19. Global Womens Health Revenue Share by Players (2019-2024)
    Table 20. Global Top Womens Health by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Womens Health as of 2023)
    Table 21. Global Womens Health Industry Ranking 2022 VS 2023 VS 2024
    Table 22. Global 5 Largest Players Market Share by Womens Health Revenue (CR5 and HHI) & (2019-2024)
    Table 23. Global Key Players of Womens Health, Headquarters and Area Served
    Table 24. Global Key Players of Womens Health, Product and Application
    Table 25. Global Key Players of Womens Health, Product and Application
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Womens Health Market Size by Type (2019-2024) & (US$ Million)
    Table 28. Global Womens Health Revenue Market Share by Type (2019-2024)
    Table 29. Global Womens Health Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 30. Global Womens Health Revenue Market Share by Type (2025-2030)
    Table 31. Global Womens Health Market Size by Application (2019-2024) & (US$ Million)
    Table 32. Global Womens Health Revenue Share by Application (2019-2024)
    Table 33. Global Womens Health Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 34. Global Womens Health Revenue Share by Application (2025-2030)
    Table 35. North America Womens Health Market Size by Type (2019-2024) & (US$ Million)
    Table 36. North America Womens Health Market Size by Type (2025-2030) & (US$ Million)
    Table 37. North America Womens Health Market Size by Application (2019-2024) & (US$ Million)
    Table 38. North America Womens Health Market Size by Application (2025-2030) & (US$ Million)
    Table 39. North America Womens Health Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 40. North America Womens Health Market Size by Country (2019-2024) & (US$ Million)
    Table 41. North America Womens Health Market Size by Country (2025-2030) & (US$ Million)
    Table 42. Europe Womens Health Market Size by Type (2019-2024) & (US$ Million)
    Table 43. Europe Womens Health Market Size by Type (2025-2030) & (US$ Million)
    Table 44. Europe Womens Health Market Size by Application (2019-2024) & (US$ Million)
    Table 45. Europe Womens Health Market Size by Application (2025-2030) & (US$ Million)
    Table 46. Europe Womens Health Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 47. Europe Womens Health Market Size by Country (2019-2024) & (US$ Million)
    Table 48. Europe Womens Health Market Size by Country (2025-2030) & (US$ Million)
    Table 49. China Womens Health Market Size by Type (2019-2024) & (US$ Million)
    Table 50. China Womens Health Market Size by Type (2025-2030) & (US$ Million)
    Table 51. China Womens Health Market Size by Application (2019-2024) & (US$ Million)
    Table 52. China Womens Health Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Womens Health Market Size by Type (2019-2024) & (US$ Million)
    Table 54. Asia Womens Health Market Size by Type (2025-2030) & (US$ Million)
    Table 55. Asia Womens Health Market Size by Application (2019-2024) & (US$ Million)
    Table 56. Asia Womens Health Market Size by Application (2025-2030) & (US$ Million)
    Table 57. Asia Womens Health Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 58. Asia Womens Health Market Size by Region (2019-2024) & (US$ Million)
    Table 59. Asia Womens Health Market Size by Region (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Womens Health Market Size by Type (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Womens Health Market Size by Type (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Womens Health Market Size by Application (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Womens Health Market Size by Application (2025-2030) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Womens Health Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 65. Middle East, Africa, and Latin America Womens Health Market Size by Country (2019-2024) & (US$ Million)
    Table 66. Middle East, Africa, and Latin America Womens Health Market Size by Country (2025-2030) & (US$ Million)
    Table 67. Allergan Company Details
    Table 68. Allergan Business Overview
    Table 69. Allergan Womens Health Product
    Table 70. Allergan Revenue in Womens Health Business (2019-2024) & (US$ Million)
    Table 71. Allergan Recent Developments
    Table 72. Bayer Company Details
    Table 73. Bayer Business Overview
    Table 74. Bayer Womens Health Product
    Table 75. Bayer Revenue in Womens Health Business (2019-2024) & (US$ Million)
    Table 76. Bayer Recent Developments
    Table 77. Merck Company Details
    Table 78. Merck Business Overview
    Table 79. Merck Womens Health Product
    Table 80. Merck Revenue in Womens Health Business (2019-2024) & (US$ Million)
    Table 81. Merck Recent Developments
    Table 82. Pfizer Company Details
    Table 83. Pfizer Business Overview
    Table 84. Pfizer Womens Health Product
    Table 85. Pfizer Revenue in Womens Health Business (2019-2024) & (US$ Million)
    Table 86. Pfizer Recent Developments
    Table 87. Teva Pharmaceutical Company Details
    Table 88. Teva Pharmaceutical Business Overview
    Table 89. Teva Pharmaceutical Womens Health Product
    Table 90. Teva Pharmaceutical Revenue in Womens Health Business (2019-2024) & (US$ Million)
    Table 91. Teva Pharmaceutical Recent Developments
    Table 92. Agile Therapeutics Company Details
    Table 93. Agile Therapeutics Business Overview
    Table 94. Agile Therapeutics Womens Health Product
    Table 95. Agile Therapeutics Revenue in Womens Health Business (2019-2024) & (US$ Million)
    Table 96. Agile Therapeutics Recent Developments
    Table 97. Amgen Company Details
    Table 98. Amgen Business Overview
    Table 99. Amgen Womens Health Product
    Table 100. Amgen Revenue in Womens Health Business (2019-2024) & (US$ Million)
    Table 101. Amgen Recent Developments
    Table 102. Apothecus Pharmaceutical Company Details
    Table 103. Apothecus Pharmaceutical Business Overview
    Table 104. Apothecus Pharmaceutical Womens Health Product
    Table 105. Apothecus Pharmaceutical Revenue in Womens Health Business (2019-2024) & (US$ Million)
    Table 106. Apothecus Pharmaceutical Recent Developments
    Table 107. AstraZeneca Company Details
    Table 108. AstraZeneca Business Overview
    Table 109. AstraZeneca Womens Health Product
    Table 110. AstraZeneca Revenue in Womens Health Business (2019-2024) & (US$ Million)
    Table 111. AstraZeneca Recent Developments
    Table 112. Blairex Laboratories Company Details
    Table 113. Blairex Laboratories Business Overview
    Table 114. Blairex Laboratories Womens Health Product
    Table 115. Blairex Laboratories Revenue in Womens Health Business (2019-2024) & (US$ Million)
    Table 116. Blairex Laboratories Recent Developments
    Table 117. Bristol-Myers Squibb Company Details
    Table 118. Bristol-Myers Squibb Business Overview
    Table 119. Bristol-Myers Squibb Womens Health Product
    Table 120. Bristol-Myers Squibb Revenue in Womens Health Business (2019-2024) & (US$ Million)
    Table 121. Bristol-Myers Squibb Recent Developments
    Table 122. Ferring Company Details
    Table 123. Ferring Business Overview
    Table 124. Ferring Womens Health Product
    Table 125. Ferring Revenue in Womens Health Business (2019-2024) & (US$ Million)
    Table 126. Ferring Recent Developments
    Table 127. Research Programs/Design for This Report
    Table 128. Key Data Information from Secondary Sources
    Table 129. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Womens Health Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Womens Health Market Share by Type: 2023 VS 2030
    Figure 3. Postmenopausal Osteoporosis Features
    Figure 4. Endometriosis Features
    Figure 5. Polycystic Ovary Syndrome Features
    Figure 6. Infertility Features
    Figure 7. Menopause Features
    Figure 8. Others Features
    Figure 9. Global Womens Health Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 10. Global Womens Health Market Share by Application: 2023 VS 2030
    Figure 11. Hospitals Case Studies
    Figure 12. Clinics Case Studies
    Figure 13. Others Case Studies
    Figure 14. Womens Health Report Years Considered
    Figure 15. Global Womens Health Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 16. Global Womens Health Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Womens Health Market Share by Region: 2023 VS 2030
    Figure 18. Global Womens Health Market Share by Players in 2023
    Figure 19. Global Top Womens Health Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Womens Health as of 2023)
    Figure 20. The Top 10 and 5 Players Market Share by Womens Health Revenue in 2023
    Figure 21. North America Womens Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. North America Womens Health Market Share by Type (2019-2030)
    Figure 23. North America Womens Health Market Share by Application (2019-2030)
    Figure 24. North America Womens Health Market Share by Country (2019-2030)
    Figure 25. United States Womens Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Canada Womens Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Europe Womens Health Market Size YoY (2019-2030) & (US$ Million)
    Figure 28. Europe Womens Health Market Share by Type (2019-2030)
    Figure 29. Europe Womens Health Market Share by Application (2019-2030)
    Figure 30. Europe Womens Health Market Share by Country (2019-2030)
    Figure 31. Germany Womens Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. France Womens Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. U.K. Womens Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Italy Womens Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Russia Womens Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Nordic Countries Womens Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. China Womens Health Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. China Womens Health Market Share by Type (2019-2030)
    Figure 39. China Womens Health Market Share by Application (2019-2030)
    Figure 40. Asia Womens Health Market Size YoY (2019-2030) & (US$ Million)
    Figure 41. Asia Womens Health Market Share by Type (2019-2030)
    Figure 42. Asia Womens Health Market Share by Application (2019-2030)
    Figure 43. Asia Womens Health Market Share by Region (2019-2030)
    Figure 44. Japan Womens Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. South Korea Womens Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. China Taiwan Womens Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Womens Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. India Womens Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Australia Womens Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Womens Health Market Size YoY (2019-2030) & (US$ Million)
    Figure 51. Middle East, Africa, and Latin America Womens Health Market Share by Type (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Womens Health Market Share by Application (2019-2030)
    Figure 53. Middle East, Africa, and Latin America Womens Health Market Share by Country (2019-2030)
    Figure 54. Brazil Womens Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Mexico Womens Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Turkey Womens Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Saudi Arabia Womens Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Israel Womens Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. GCC Countries Womens Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. Allergan Revenue Growth Rate in Womens Health Business (2019-2024)
    Figure 61. Bayer Revenue Growth Rate in Womens Health Business (2019-2024)
    Figure 62. Merck Revenue Growth Rate in Womens Health Business (2019-2024)
    Figure 63. Pfizer Revenue Growth Rate in Womens Health Business (2019-2024)
    Figure 64. Teva Pharmaceutical Revenue Growth Rate in Womens Health Business (2019-2024)
    Figure 65. Agile Therapeutics Revenue Growth Rate in Womens Health Business (2019-2024)
    Figure 66. Amgen Revenue Growth Rate in Womens Health Business (2019-2024)
    Figure 67. Apothecus Pharmaceutical Revenue Growth Rate in Womens Health Business (2019-2024)
    Figure 68. AstraZeneca Revenue Growth Rate in Womens Health Business (2019-2024)
    Figure 69. Blairex Laboratories Revenue Growth Rate in Womens Health Business (2019-2024)
    Figure 70. Bristol-Myers Squibb Revenue Growth Rate in Womens Health Business (2019-2024)
    Figure 71. Ferring Revenue Growth Rate in Womens Health Business (2019-2024)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed